Literature DB >> 6177386

Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.

T Yoneda, G R Mundy.   

Abstract

The bone resorbing lymphokine osteoclast activating factor (OAF) is released by lymphocytes activated by phytohemagglutinin (PHA). In this study we have found that release of OAF by activated lymphocytes is dependent on cyclic AMP (cAMP). OAF release is preceded by cAMP accumulation in the lymphocytes, and when cAMP accumulation is impaired by treatment of activated leukocytes with indomethacin, OAF is not released. OAF release in these cultures is restored by the addition of agents that mimic or increase lymphocyte cAMP content by different mechanisms. When activated purified lymphocytes that do not release OAF by themselves were cultured with these agents, OAF appeared in the culture media. These results suggest that cyclic AMP accumulation in lymphocytes is required for OAF to be released after activation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177386     DOI: 10.1007/BF02411234

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  19 in total

1.  Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis.

Authors:  T Wang; J R Sheppard; J E Foker
Journal:  Science       Date:  1978-07-14       Impact factor: 47.728

2.  Control of lymphocyte function.

Authors:  H L Bleich; E S Boro
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

3.  Big and little forms of osteoclast activating factor.

Authors:  G R Mundy; L G Raisz; J L Shapiro; J G Bandelin; R J Turcotte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  Prevention of MIF activity by agents known to increase cellular cyclic AMP.

Authors:  W J Koopman; M H Gillis; J R David
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

5.  Macrophage-lymphocyte synergy in the production of osteoclast activating factor.

Authors:  J E Horton; J J Oppenheim; S E Mergenhagen; L G Raisz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

Review 6.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

7.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

8.  Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.

Authors:  K L Melmon; H R Bourne; Y Weinstein; G M Shearer; J Kram; S Bauminger
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

9.  Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.

Authors:  J W Smith; A L Steiner; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

10.  Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes.

Authors:  T Yoneda; G R Mundy
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  2 in total

1.  Effects of keratin on bone resorption in experimental otitis media.

Authors:  H Moriyama; C C Huang; Y Shirahata; M Abramson
Journal:  Arch Otorhinolaryngol       Date:  1984

Review 2.  Cytokines and other mediators in rheumatoid arthritis.

Authors:  J M Dayer; S Demczuk
Journal:  Springer Semin Immunopathol       Date:  1984
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.